Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for MONTE ROSA THERAPEUTICS INC COMMON STOCK (GLUE).
- Disclosed ownership: 7.5%.
- Date of event: 30 Sep 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 30 Sep 2025 SCHEDULE 13G/A Report for MONTE ROSA THERAPEUTICS INC COMMON STOCK (GLUE)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Symbol
- GLUE
- Shares outstanding
- 61,827,467 shares
- Disclosed Ownership
- 4,637,060 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 12:19:23 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 7.5% ownership in MONTE ROSA THERAPEUTICS INC COMMON STOCK (GLUE) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 12:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 7.5% | 4,637,060 | 4,523,852 | 0 | Ellen York | Vice President |